Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1431]

Shape-shifting cells help skin cancer spread

Shape-shifting cells help skin cancer spread

Half of UK will get cancer in their lifetime by 2020

Half of UK will get cancer in their lifetime by 2020

ASCO 2013: New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

ASCO 2013: New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

ASCO 2013: Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

ASCO 2013: Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

ASCO 2013: Adding GM-CSF to ipilimumab significantly improves survival compared to ipilimumab alone in patients with metastatic melanoma

ASCO 2013: Adding GM-CSF to ipilimumab significantly improves survival compared to ipilimumab alone in patients...

FDA approves the use of dabrafenib for treatment of metastatic melanoma

FDA approves the use of dabrafenib for treatment of metastatic melanoma

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

Promising strategies to reduce use of indoor tanning devices and prevent skin cancer

Promising strategies to reduce use of indoor tanning devices and prevent skin cancer

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

More from ecancer